Experience with a metered-dose inhaler with a spacer in the pediatric emergency department.

Studies of adults suggest that metered-dose inhalers with spacers are as effective as hand-held nebulizers for bronchodilator delivery. We studied 13 children with acute asthma. They received two puffs every 2 minutes from metered-dose inhalers with spacers (range, 4 to 14 puffs) titrated until improvement stopped. Peak expiratory flow increased 34% for metered-dose inhalers with spacers after the first 2 puffs and increased 87% for metered-dose inhalers with spacers after dose titration. After titration, respiratory rate decreased by 12%, heart rate increased by 2%, and breath sounds improved in 92% of the patients. We concluded that the metered-dose inhalers with spacers are an effective device for the treatment of asthma in the pediatric emergency department and that the use of metered-dose inhalers with spacers with titration can achieve significant bronchodilation in the treatment of patients with acute asthma.

Calibration of a heated transcutaneous carbon dioxide electrode to reflect arterial carbon dioxide.

The CO2 measured by a heated skin surface electrode is greater than arterial CO2. In this study we (1) determined the magnitude of this difference retrospectively, (2) adjusted the calibration of the heated transcutaneous CO2 electrode to reflect this difference, and (3) tested the validity of the calibration procedure prospectively. The retrospective study consisted of 252 simultaneous arterial and transcutaneous measurements on 38 infants and children (age range, 1 day to 6 yr). A linear regression analysis showed PtcCO2 = 1.61 X PaCO2 - 0.01 mmHg, r = 0.90 (p less than 0.0001). Because the intercept was virtually zero, we subsequently changed the calibration procedure by dividing the transcutaneous electrode reading by 1.61. The prospective study consisted of 269 more simultaneous arterial and transcutaneous measurements from 57 consecutive infants and children (age range, 1 day to 18 yr) using this calibration procedure. Regression analysis showed PtcCO2 = 1.02 X PaCO2 - 2.3 mmHg, r = 0.96 (p less than 0.0001). Thus, we found that the transcutaneous CO2 electrode, using this technique, reliably predicted the arterial CO2.

Continuous transcutaneous oxygen and carbon dioxide monitoring in the pediatric ICU.

The transcutaneous partial pressures of carbon dioxide (PtcCO2) and oxygen (PtcO2) were measured with heated electrodes in 18 hemodynamically stable pediatric ICU patients and these data were compared to simultaneously measured arterial oxygen and carbon dioxide tensions. There was a significant degree of correlation (p less than 0.001) between the skin surface CO2 and O2 and their corresponding arterial tensions. These data defined values for PtcCO2 and PtcO2 indices in the pediatric patient without cardiovascular complications as PtcCO2 index = 1.6 +/- 0.2 and the PtcO2 index = 0.84 +/- 0.18 (PtcCO2 index = PtcCO2/PaCO2 and PtcO2 index = PtcO2/PaO2). The authors found the monitoring of skin surface gases a reliable technique to monitor arterial gas tension in hemodynamically stable patients.

Transcutaneous measurements of carbon dioxide partial pressure in sick neonates.

The authors measured the partial pressure of carbon dioxide transcutaneously (PtcCO2) in 15 sick newborns and compared the PtcCO2 to simultaneously measured partial pressure of arterial carbon dioxide (PaCO2). The PtcCO2 values reflected changes in the PaCO2 values. A linear regression on 106 paired PtcCO2 and PaCO2 values produced a correlation coefficient of 4 = 0.91 with a slope of 1.89 and a y-intercept of --9.4. The authors found the measurement of PtcCO2 to be a clinically useful method of continuously following the trend of PaCO2.